Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR Pathways

Regardless of the presence or absence of specific diagnostic mutations, many cancer patients fail to respond to EGFR-targeted therapeutics, and a personalized approach is needed to identify putative (non)responders. We found previously that human peripheral blood and EGF can modulate the activities...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Dmitri Kamashev, Nina Shaban, Timofey Lebedev, Vladimir Prassolov, Maria Suntsova, Mikhail Raevskiy, Nurshat Gaifullin, Marina Sekacheva, Andrew Garazha, Elena Poddubskaya, Maksim Sorokin, Anton Buzdin
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	MDPI AG 2023-08-01
Reeks:	Cells
Onderwerpen:	EGFR HER-targeted cancer therapy human blood serum cetuximab erlotinib EGF
Online toegang:	https://www.mdpi.com/2073-4409/12/16/2022
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!